pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
KSP-1007
Ventilator Associated Pneumonia (VAP)
Sumitomo Pharma Co Ltd
0
catalysts
Phase 2
KSQ-001
Head And Neck Squamous Cell Carcinoma (HNSC)
KSQ Therapeutics Inc
0
catalysts
Phase 2
KSQ-004
Acral Lentiginous Melanoma
KSQ Therapeutics Inc
0
catalysts
Phase 1
KST-6051
Metastatic Colorectal Cancer
← prev
page 115 of 271
next →
131
Pain
89
Neurology
1
$KG
Kestrel Group Ltd
0
catalysts
Preclinical
KT-20610
Autism Spectrum Disorder (ASD)
Kingdom Therapeutics Ltd
0
catalysts
Phase 2
KT-621
Eosinophilic Asthma
$KYMR
Kymera Therapeutics, Inc.
0
catalysts
Phase 2
KTP-001
Lumbar Hernia/Bleichner's Hernia
Teijin Pharma Ltd
0
catalysts
Phase 1
KTX-2001
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
K36 Therapeutics Inc
0
catalysts
Phase 2
KUS-121
Retinal Artery Occlusion
Kyoto Drug Discovery & Development Co Ltd
0
catalysts
Phase 1
KY-0118
Colorectal Cancer
Shanghai Keyi Pharmaceutical Technology Co Ltd
0
catalysts
Preclinical
KY-0601
Colorectal Cancer
Novatim Immune Therapeutics (Zhejiang) Co Ltd
0
catalysts
Preclinical
KY-0901
Bile Duct Cancer (Cholangiocarcinoma)
Novatim Immune Therapeutics (Zhejiang) Co Ltd
0
catalysts
KYGEVVI
KYGEVVI (DOXECITINE)
UCB SA
0
catalysts
Marketed
Kcentra
Kcentra ((coagulation factor II (human) + coagulation factor VII (human) + coagulation factor IX (human) + coagulation factor X (human) + protein C (human) + protein S (human)))
Bleeding And Clotting Disorders
CSL Behring LLC
0
catalysts
Marketed
Kenalog
Kenalog (triamcinolone acetonide)
Atopic Dermatitis (Atopic Eczema)
Sun Pharmaceutical Industries Ltd
0
catalysts
Phase 2
Ketamir-2
Chemotherapy Induced Peripheral Neuropathy
Miralogx LLC
0
catalysts
Marketed
Ketotifen Fumarate Apotex
Ketotifen Fumarate (ketotifen fumarate)
Allergic Conjunctivitis
Apotex Corp
0
catalysts
Marketed
Kimyrsa
Kimyrsa (oritavancin [INN])
Skin And Skin Structure Infections (SSSI) Caused By Bacteria
Melinta Therapeutics LLC
0
catalysts
Preclinical
Kindolor
Diabetic Neuropathy
Lohocla Research Corp
0
catalysts
Marketed
Klaron
Sulfacetamide Sodium Oceanside (sulfacetamide sodium)
Acne Vulgaris
Bausch Health Americas Inc
0
catalysts
Marketed
Klor-Con
Klor-Con (potassium chloride)
Hypokalemia
Upsher-Smith Laboratories LLC
0
catalysts
Marketed
Kloxxado
Kloxxado (naloxone hydrochloride)
Acute Opioid Overdosage
Hikma Pharmaceuticals USA Inc
0
catalysts
Marketed
Kovaltry
Kovaltry (antihemophilic factor (recombinant))
Hemophilia A (Factor VIII Deficiency)
Bayer HealthCare Pharmaceuticals Inc
0
catalysts
Preclinical
Kuragenx
Neurotrophic Keratitis
Pandorum Technologies Pvt Ltd
0
catalysts
Marketed
Kyleena
Kyleena (levonorgestrel)
Female Contraception
Bayer AG
0
catalysts
Phase 1
L-130
Generalized Anxiety Disorder (GAD)
Cynaptec Pharmaceuticals Inc
0
catalysts
Phase 2
L-Citrulline
Sickle Cell Disease With Vaso-Occlusive Crisis
Asklepion Pharmaceuticals LLC
0
catalysts
LACOSAMIDE ORAL SOLUTION
LACOSAMIDE ORAL SOLUTION (LACOSAMIDE ORAL SOLUTION)
ALKEM LABS LTD
0
catalysts
LACRISERT
LACRISERT (HYDROXYPROPYL CELLULOSE)
BAUSCH AND LOMB INC
0
catalysts
LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER
LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE)
Baxter Healthcare Corp
0
catalysts
